Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | US biotech companies gross profit margin Q4 2017

Gross profit margin of select U.S. biotech and drugs companies Q4 2017

Gross profit margin of selected U.S. biotech and drugs companies in Q4 2017

The data displays the gross profit margin of selected U.S.-based biotech and drugs companies in the fourth quarter of 2017. In that quarter, U.S. biotech company AbbVie reported an profit margin of 70.54%. In general, profit margins are very high among biotech companies. Some companies, like Foamix Pharmaceuticals, have margins of nearly 100%.

Foamix Pharmaceuticals 99.95
Seattle Genetics 92.12
Allergan 86.57
Biogen 84.6
Amgen 81.75
Nanostring Technologies 79.65
Gilead Sciences 78.89
Entia Biosciences 77.99
Abbvie 70.54
Emergent Biosolutions 63.75
Asterias Biotherapeutics 53.57

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.